NovaBridge Biosciences Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
NovaBridge Biosciences (NBP) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of -$42.07 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2026-04-07
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2025-12-31 | -$42.07M 20-F · filed 2026-04-07 |